Alessandro Sciarra. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Adrenergic alpha-Antagonists/therapeutic useAge FactorsAgedDrug Therapy, CombinationEnzyme Inhibitors/therapeutic useErectile Dysfunction/drug therapyErectile Dysfunction/epidemiologyErectile Dysfunction/etiologyHumansMaleMiddle AgedPiperazines/therapeutic usePrevalenceProstatic Hyperplasia/complicationsProstatic Hyperplasia/epidemiologyPurines/therapeutic useQuality of LifeQuinazolines/therapeutic useRisk FactorsSildenafil CitrateSulfones/therapeutic useUrination Disorders/drug therapyUrination Disorders/epidemiologyUrination Disorders/etiology
Substances： See more » Adrenergic alpha-AntagonistsEnzyme InhibitorsPiperazinesPurinesQuinazolinesSulfonesalfuzosinSildenafil Citrate
Year: 2007 PMID： 17275984 DOI： 10.1016/j.eururo.2007.01.065
Source DB: PubMed Journal: Eur Urol ISSN： 0302-2838 Impact factor: 20.096